APA (7th ed.) Citation

Liu, J., Zhao, X., Chang, Y., Qin, Y., Jiang, Q., Jiang, H., . . . Zhao, X. (2025). Monitoring the KMT2A gene post‐chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantation. British journal of haematology, 206(5), 1418-1429. https://doi.org/10.1111/bjh.20036

Chicago Style (17th ed.) Citation

Liu, Jing, et al. "Monitoring the KMT2A Gene Post‐chemotherapy Independently Predicts the Relapse and Survival Risk After Allogeneic Haematopoietic Stem Cell Transplantation." British Journal of Haematology 206, no. 5 (2025): 1418-1429. https://doi.org/10.1111/bjh.20036.

MLA (9th ed.) Citation

Liu, Jing, et al. "Monitoring the KMT2A Gene Post‐chemotherapy Independently Predicts the Relapse and Survival Risk After Allogeneic Haematopoietic Stem Cell Transplantation." British Journal of Haematology, vol. 206, no. 5, 2025, pp. 1418-1429, https://doi.org/10.1111/bjh.20036.